Portal:CPTAC/Hallmark/Proliferative

From WikiPathways

Revision as of 00:34, 28 September 2018 (view source) Khanspers (Talk | contribs) ← Previous diff		Revision as of 00:41, 28 September 2018 (view source) Khanspers (Talk | contribs) Next diff →
Line 5:		Line 5:
	*[[Pathway:WP4223]] Ras Signaling		*[[Pathway:WP4223]] Ras Signaling
	*[[Pathway:WP2828]] Bladder Cancer		*[[Pathway:WP2828]] Bladder Cancer
		+	*[[Pathway:WP4205]] MET in type 1 papillary renal cell carcinoma

---

Revision as of 00:41, 28 September 2018

• Pathway:WP3972 PDGFR-beta pathway
• Pathway:WP673 ErbB Signaling Pathway
• Pathway:WP581 EPO Receptor Signaling
• Pathway:WP382 MAPK Signaling Pathway
• Pathway:WP4223 Ras Signaling
• Pathway:WP2828 Bladder Cancer
• Pathway:WP4205 MET in type 1 papillary renal cell carcinoma